Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 850 mg, hypromellosum, natrii carbonas, povidonum k 25, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, e 171, pro compresso obducto corresp. natrium 1.84 mg. - typ 2 -diabetes - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 1000 mg, hypromellosum, natrii carbonas, povidonum k 25, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, e 171, pro compresso obducto corresp. natrium 2.17 mg. - typ 2 -diabetes - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - metformina - metformina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - metformina - metformina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

laboratori alter s.r.l. - metformina - metformina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

viatris limited - metformina e vildagliptin - metformina e vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

adamed s.r.l. - metformina e sitagliptina - metformina e sitagliptina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bruno farmaceutici s.p.a. - metformina e sitagliptina - metformina e sitagliptina

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - farmaci usati nel diabete - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.